Cleveland BioLabs Inc. (NASDAQ: CBLI) started the day on June 26, 2020, with a price increase of 147.67% at $4.26. During the day, the stock rose to $4.43 and sunk to $1.72 before settling in for the price of $1.72 at the close. Taking a more long-term approach, CBLI posted a 52-week range of $0.50-$5.00.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -21.40%. Meanwhile, its Annual Earning per share during the time was -19.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.70%. This publicly-traded company’s shares outstanding now amounts to $11.35 million, simultaneously with a float of $5.58 million. The organization now has a market capitalization sitting at $22.19 million. At the time of writing, stock’s 50-day Moving Average stood at $1.82, while the 200-day Moving Average is $1.48.
While finding the extent of efficiency of the company that is accounted for 7 employees. It has generated 92,785 per worker during the last fiscal year. Meanwhile, its income per employee was -220,582. The stock had 3.53 Receivables turnover and 0.34 Total Asset turnover. For the Profitability, stocks operating margin was -212.03 and Pretax Margin of -242.02.
Cleveland BioLabs Inc. (CBLI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Cleveland BioLabs Inc.’s current insider ownership accounts for 64.39%, in contrast to 3.20% institutional ownership.
Cleveland BioLabs Inc. (CBLI) Earnings and Revenue Records
This company achieved a net margin of -237.73.
Cleveland BioLabs Inc.’s EPS increase for this current 12-month fiscal period is 26.70%.
Cleveland BioLabs Inc. (NASDAQ: CBLI) Trading Performance Indicators
Let’s observe the current performance indicators for Cleveland BioLabs Inc. (CBLI). It’s Quick Ratio in the last reported quarter now stands at 1.70. The Stock has managed to achieve an average true range (ATR) of 0.34. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.18.
In the same vein, CBLI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.21.
Technical Analysis of Cleveland BioLabs Inc. (CBLI)
If we take a close look at the recent performances of Cleveland BioLabs Inc. (NASDAQ: CBLI), its last 5-days Average volume was 10.6 million that shows progress from its year to date volume of 1.12 million. During the previous 9 days, stock’s Stochastic %D was recorded 81.34% While, its Average True Range was 0.44.
Raw Stochastic average of Cleveland BioLabs Inc. (CBLI) in the period of the previous 100 days is set at 80.16%, which indicates a major fall in contrast to 94.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 373.69% that was higher than 211.55% volatility it exhibited in the past 100-days period.